Kopion Asset Management LLC trimmed its stake in shares of Cognex Corporation (NASDAQ:CGNX – Free Report) by 29.4% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 200,729 shares of the scientific and technical instruments company’s stock after selling 83,464 shares during the period. Cognex accounts for 5.9% of Kopion Asset Management LLC’s holdings, making the stock its 7th biggest position. Kopion Asset Management LLC’s holdings in Cognex were worth $9,093,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors and hedge funds have also modified their holdings of the company. Nordea Investment Management AB raised its holdings in Cognex by 148.5% in the 2nd quarter. Nordea Investment Management AB now owns 7,075,772 shares of the scientific and technical instruments company’s stock valued at $223,594,000 after acquiring an additional 4,228,729 shares during the last quarter. PNC Financial Services Group Inc. boosted its holdings in shares of Cognex by 121.5% during the 2nd quarter. PNC Financial Services Group Inc. now owns 12,990 shares of the scientific and technical instruments company’s stock worth $412,000 after purchasing an additional 7,126 shares during the last quarter. World Investment Advisors purchased a new stake in shares of Cognex in the second quarter valued at approximately $204,000. Creative Planning increased its holdings in shares of Cognex by 49.1% in the second quarter. Creative Planning now owns 62,525 shares of the scientific and technical instruments company’s stock valued at $1,983,000 after purchasing an additional 20,587 shares during the last quarter. Finally, Teacher Retirement System of Texas increased its holdings in shares of Cognex by 7.9% in the second quarter. Teacher Retirement System of Texas now owns 52,502 shares of the scientific and technical instruments company’s stock valued at $1,665,000 after purchasing an additional 3,862 shares during the last quarter. Hedge funds and other institutional investors own 88.12% of the company’s stock.
Insider Buying and Selling
In other news, Director Robert Willett sold 6,704 shares of the firm’s stock in a transaction on Tuesday, October 21st. The stock was sold at an average price of $49.51, for a total transaction of $331,915.04. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 1.60% of the stock is owned by company insiders.
Cognex Trading Down 0.6%
Cognex (NASDAQ:CGNX – Get Free Report) last announced its quarterly earnings results on Wednesday, October 29th. The scientific and technical instruments company reported $0.33 earnings per share for the quarter, beating analysts’ consensus estimates of $0.27 by $0.06. The business had revenue of $264.00 million during the quarter, compared to analysts’ expectations of $261.86 million. Cognex had a net margin of 11.33% and a return on equity of 8.26%. The business’s revenue for the quarter was up 18.0% on a year-over-year basis. During the same period last year, the business earned $0.20 earnings per share. Cognex has set its Q4 2025 guidance at 0.190-0.24 EPS. Equities research analysts forecast that Cognex Corporation will post 0.61 earnings per share for the current year.
Cognex Increases Dividend
The company also recently announced a quarterly dividend, which was paid on Friday, November 28th. Shareholders of record on Thursday, November 13th were given a $0.085 dividend. The ex-dividend date of this dividend was Thursday, November 13th. This is a positive change from Cognex’s previous quarterly dividend of $0.08. This represents a $0.34 dividend on an annualized basis and a yield of 0.9%. Cognex’s dividend payout ratio is presently 53.13%.
Analyst Ratings Changes
CGNX has been the topic of a number of recent research reports. Truist Financial lowered their price objective on Cognex from $45.00 to $42.00 and set a “hold” rating on the stock in a research note on Thursday, December 18th. KeyCorp reissued an “overweight” rating and set a $50.00 price target on shares of Cognex in a research report on Friday, October 31st. The Goldman Sachs Group upgraded shares of Cognex from a “sell” rating to a “buy” rating and raised their price objective for the stock from $42.00 to $50.00 in a research report on Tuesday, December 16th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Cognex in a research note on Monday, December 15th. Finally, Robert W. Baird set a $45.00 price target on shares of Cognex in a research note on Friday, October 31st. Nine analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $45.79.
Read Our Latest Report on Cognex
Cognex Company Profile
Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.
The company’s product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.
See Also
- Five stocks we like better than Cognex
- Do not delete, read immediately
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- Can Any Expenses Be Deducted From Capital Gains Tax?
- The Last Gold Bull Market
Want to see what other hedge funds are holding CGNX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cognex Corporation (NASDAQ:CGNX – Free Report).
Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with MarketBeat.com's FREE daily email newsletter.
